 | Up a level |
Mozes, Ferenc E. and Lee, Jenny A. and Vali, Yasaman and Selvaraj, Emmanuel A. and Jayaswal, Arjun N. A. and Boursier, Jerome and de Ledinghen, Victor and Lupsor-Platon, Monica and Yilmaz, Yusuf and Chan, Wah-Kheong and Mahadeva, Sanjiv and Karlas, Thomas and Wiegand, Johannes and Tsochatzis, Emmanouil and Liguori, Antonio and Wong, Vincent Wai-Sun and Lee, Dae Ho and Holleboom, Adriaan G. and van Dijk, Anne-Marieke and Mak, Anne Linde and Hagstroem, Hannes and Akbari, Camilla and Hirooka, Masashi and Lee, Dong Hyeon and Kim, Won and Okanoue, Takeshi and Shima, Toshihide and Nakajima, Atsushi and Yoneda, Masato and Thuluvath, Paul J. and Li, Feng and Berzigotti, Annalisa and Mendoza, Yuly P. and Noureddin, Mazen and Truong, Emily and Fournier-Poizat, Celine and Geier, Andreas and Tuthill, Theresa and Yunis, Carla and Anstee, Quentin M. and Harrison, Stephen A. and Bossuyt, Patrick M. and Pavlides, Michael (2024) Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver International, 44 (8). pp. 1872-1885. ISSN 1478-3223, DOI https://doi.org/10.1111/liv.15914.
Park, Keunchil and Janne, Pasi A. and Kim, Dong-Wan and Han, Ji-Youn and Wu, Ming-Fang and Lee, Jong-Seok and Kang, Jin-Hyoung and Lee, Dae Ho and Cho, Byoung Chul and Yu, Chong-Jen and Pang, Yong Kek and Felip, Enriqueta and Kim, Hyunjin and Baek, Eunhye and Noh, Young Su (2021) Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer, 127 (9). pp. 1407-1416. ISSN 0008-543X, DOI https://doi.org/10.1002/cncr.33385.
